In a letter to Prime Minister Narendra Modi, the Alliance of Doctors for Ethical Healthcare (ADEH) said that these drugs and implants are also accused of "exorbitantly" like coronary stents. ADEH has also attached documents to show how drug providers, especially those for cancer, and knee and hip replacement implants are exorbitant prices, sometimes 200 percent more than the actual price.
Wanting the Center's decision to put a ceiling on coronary stent prices, a group of doctors sought a similar ceiling on drug prices, hip and knee implants and lenses. It welcomed the government's decision to put a ceiling on the price of coronary stents and credited the Prime Minister for this "revolutionary" measure.
"ADEH urges the Prime Minister to put a ceiling on the prices of medicines, especially generic and cancer drugs, as well as on intraocular lenses and knee and hip replacement implants as they are also charged Exorbitant as the coronary stents, "GS Committee members Grewal and Arun Mitra said. There is a practice of "hospital rate" and "MRP" which is not only "unethical, but criminal," they said.
They said an unsuspecting patient has no reason or way not to pay MRP mentioned on drugs or implants, which is highly "inflated and exorbitant" and asserted that MRP on drugs and implants must be meticulously monitored and regulated.
"There is a dirty tendency in the healthcare system where drug manufacturers, including the major and major ones, provide medicines and medicines to hospitals at a much cheaper price than the MRP mentioned on drugs,they said in letter. Prices should be fixed after full assessment of the cost and that should be mentioned on the drugs, they said.
It had said the decision by the National Pharmaceutical Pricing Authority (NPPA) to cap the prices of life-saving stents will hit the profits of these hospitals which were absolutely "unethical and criminal".
